Open Nav

BioXcel Therapeutics

  • Vimal Mehta, BioXcel Therapeutics

Investor Awareness

  • Date:Wednesday, October 17
  • Time:10:45 AM - 11:00 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Publicly Traded Company
  • Company Description/Mission Statement:A Clinical Stage Biopharmaceutical Company Advancing the Next Wave of Medicines in Neuroscience & Immuno-Oncology.
  • Company Website:http://www.bioxceltherapeutics.com/
  • Company HQ City:New Haven
  • Company HQ Country:United States
  • Company HQ State:Connecticut              
  • Ticker:BTAI
  • Exchange:Nasdaq
  • Main Therapeutic Focus:CNS/Neurological
  • Lead Product in Development :BXCL501
  • Development Phase of Primary Product:Phase I
Speakers
Vimal Mehta
BioXcel Therapeutics
Back